Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CHANGE Holdings, Oct-Dec (3Q) Net Income Increases by 61%
3962 CHANGE Holdings, Inc. 【IFRS】
Earnings ReportCHANGE Holdings, Inc. <3962> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 13th (15:30). The consolidated net income for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 18.8% from the same period last year, reaching 8.26 billion yen. The progress rate toward the full-year plan of 8.06 billion yen is 102.4%, but it was lower than the same period of the previous year of 160.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the January to March period (4Q) is expected to further decrease loss of 0.19 billion yen (compared to a loss of 2.62 billion yen in the same period last year).
In the most recent three-month period, from October to December (3Q), the consolidated net income increased 61.2% from the same period last year, reaching 6.15 billion yen. The operating profit margin rose from 41.5% in the same period last year to 50.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 15,519 | 5,188 | 5,126 | 3,609 | 49.9 | 90.7 | Feb 14, 2023 | IFRS |
Apr - Dec, 2023 | 28,798 | 10,199 | 10,194 | 6,951 | 96.1 | 140.6 | Feb 14, 2024 | IFRS |
Apr - Dec, 2024 | 34,937 | 13,121 | 12,589 | 8,260 | 117.6 | 98.2 | Feb 13, 2025 | IFRS |
YoY | +21.3% | +28.6% | +23.5% | +18.8% | +22.4% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 22,358 | 3,054 | 2,873 | 1,131 | 15.6 | 18.70 | May 15, 2024 | IFRS |
Oct - Mar, 2024 Guidance | 28,488 | 9,152 | 9,326 | 5,965 | 85.7 | 14.50 | Nov 13, 2024 | IFRS |
YoY | +27.4% | +199.7% | +224.6% | +427.4% | +448.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 20,021 | 5,730 | 5,653 | 3,856 | 53.3 | 10 | May 15, 2023 | IFRS |
Mar, 2024 | 37,015 | 7,383 | 7,250 | 4,262 | 58.9 | 18.70 | May 15, 2024 | IFRS |
Mar, 2025 Guidance | 45,000 | 13,000 | 12,815 | 8,069 | 116.0 | 14.50 | May 15, 2024 | IFRS |
YoY | +21.6% | +76.1% | +76.8% | +89.3% | +96.9% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 14,141 | 5,870 | 5,817 | 3,820 | 52.8 | 41.5 | Feb 14, 2024 | IFRS |
Jan - Mar, 2024 | 8,217 | -2,816 | -2,944 | -2,689 | -37.2 | -34.3 | May 15, 2024 | IFRS |
Apr - Jun, 2024 | 8,139 | 2,453 | 2,285 | 1,432 | 20.0 | 30.1 | Aug 14, 2024 | IFRS |
Jul - Sep, 2024 | 8,373 | 1,395 | 1,204 | 672 | 9.5 | 16.7 | Nov 13, 2024 | IFRS |
Oct - Dec, 2024 | 18,425 | 9,273 | 9,100 | 6,156 | 87.7 | 50.3 | Feb 13, 2025 | IFRS |
YoY | +30.3% | +58.0% | +56.4% | +61.2% | +66.0% |
Related Articles
StemCell Institute, Oct-Dec (3Q) Ordinary Profit Decreases by 27%
PORT, Apr-Dec (Cumulative 3Q) Net Income Increases by 35%, Oct-Dec Net Income Increases by 98%
Grandy House, Oct-Dec (3Q) Ordinary Profit Increases by 2.1 times
GINZA YAMAGATAYA, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Decreases by 36%
Raysum, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 59%, Oct-Dec Ordinary Profit Turns to Loss
Innovation Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 42%, Oct-Dec Ordinary Profit Increases by 90%
KLab, Last Fiscal Year's Ordinary Profit Loss Widens, Current period performance is undisclosed.
TABIKOBO, Oct-Dec (2Q) Ordinary Profit Loss Narrows
TAKARA BIO, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 12% Decrease
Relo Group, The Current Fiscal Year Net Income Revised Upward by 21%, Exceeded Record Profit Forecast